Karolinska Development
 

View full portfolio and sort by:

   

Solid colored area = completed phase                  Shaded colored area = ongoing phase

 

Pharmaceuticals

Oncology Concept Development Lead Discovery Lead Optimization Preclinical Development Phase I Phase II Phase III Launch

Axelar AB

KDev Oncology AB (AKN-028)

Aprea AB

Oncopeptides AB

KDev Oncology AB (GliGene)
Dermatology and Wound Healing Concept Development Lead Discovery Lead Optimization Preclinical Development Phase I Phase II Phase III Launch

Pergamum AB (DPK-060, atopic dermatitis)

Pergamum AB (PXL01)

Pergamum AB (DPK-060, external otitis)

Pergamum AB (LL-37)
Women's Health Concept Development Lead Discovery Lead Optimization Preclinical Development Phase I Phase II Phase III Launch

Dilafor AB

Umecrine Mood AB

Pharmanest AB

Infectious Disease Concept Development Lead Discovery Lead Optimization Preclinical Development Phase I Phase II Phase III Launch

Dilaforette AB

Biosergen AS

Cardiovascular Concept Development Lead Discovery Lead Optimization Preclinical Development Phase I Phase II Phase III Launch

Athera Biotechnologies AB (Annexin A5)

Athera Biotechnologies AB (PC-mAb)
CNS Concept Development Lead Discovery Lead Optimization Preclinical Development Phase I Phase II Phase III Launch

BioChromix Pharma AB

Umecrine Cognition AB

Inflammation Concept Development Lead Discovery Lead Optimization Preclinical Development Phase I Phase II Phase III Launch

NovaSAID AB

ProNoxis AB

Ophthalmology Concept Development Lead Discovery Lead Optimization Preclinical Development Phase I Phase II Phase III Launch

Clanotech AB

Technology

Implants Concept Development Prototype Development Product Sales

Promimic AB

Oss-Q AB

Diagnostics Concept Development Prototype Development Product Sales

Athera Biotechnologies AB (lgM anti-PC (CVDefine kit))

BioChromix AB

Pharmaceutical Formulation Concept Development Prototype Development Product Sales

XSpray Microparticles AB

Inhalation Sciences Sweden AB

Lipidor AB

Medical Equipment Concept Development Prototype Development Product Sales

NeoDynamics AB (Fourier/AS)

NeoDynamics AB ((Therapy/PRFA) Anti-Meta)

Passive/Financial Investments

Pharmaceuticals Concept Development Lead Discovery Lead Optimization Preclinical Development Phase I Phase II Phase III Launch

Pergamum AB (Laurantis Pharma Oy) (cis-UCA dermatology)

NephroGenex Inc.

BioArctic Neuroscience AB

Pergamum AB (Laurantis Pharma Oy) (cis-UCA oncology)

Pergamum AB (Laurantis Pharma Oy) (ad-VEGF-C)

CytoGuide ApS